Relapsed/refractory Waldenström macroglobulinemia (WM)

Clinical trials for Relapsed/refractory Waldenström macroglobulinemia (WM) explained in plain language.

Never miss a new study

Get alerted when new Relapsed/refractory Waldenström macroglobulinemia (WM) trials appear

Sign up with your email to follow new studies for Relapsed/refractory Waldenström macroglobulinemia (WM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill takes on Hard-to-Treat blood cancers

Disease control Recruiting now

This early-stage trial tests a daily pill called APG-3288 in 180 adults with blood cancers like leukemia or lymphoma that have come back or not responded to standard treatments. The main goals are to find the safest dose and check for side effects. Researchers will also look for …

Matched conditions: RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)

Phase 1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

Relapsed/refractory Waldenström macroglobulinemia (WM)

Get alerted when new Relapsed/refractory Waldenström macroglobulinemia (WM) trials appear

New pill takes on Hard-to-Treat blood cancers